The content of this presentation is provided to an audience of international healthcare professionals from around the world for scientific discussion and scientific exchange. Bayer does not recommend the use of any drug substance outside of its approved indications.

At the moment of publication, the compound presented has been only approved by Food and Drug Administration (FDA) and European Medicines Agency (EMA). For other approvals, follow your local regulations or health authorities legislation.

European Society of Cardiology 2022Satellite Symposium Presentations August 26–29, 2022

Presentations of the Bayer Satellite Symposium at the ESC Congress 2022

Thank you for your interest! Please see below to download PDFs of the presentation of the Bayer Satellite Symposium at the ESC Congress 2022. Access to the presentations will be available after the congress presentation.

Finerenone

Sunday 28 August, 2022 | 12:45-13:45 CEST
Cardiorenal benefits of finerenone: Protecting the heart and kidneys

Showreel

Session: Satellite SymposiumSpeaker: Adriaan Voors, George Bakris, Gerasimos Filippatos, Johann Bauersachs and Pam Taub

Doc Icon

Download the Slide Deck

The compendium provided by Bayer is a compilation of Bayer-sponsored presentations. Copies of presentations obtained from this compendium are for personal use only and may not be reproduced or distributed without permission from European Society of Cardiology 70th Annual Meeting and from the authors.

Reused with permission. © 2022 European Society of Cardiology 70th Annual Meeting. All rights reserved.

For any questions, please contact Medical Information at 1-888-84-BAYER (1-888-842-2937), or visit go.bayer.com/vPIR.

MA-M_FIN-ALL-0985-1

© 2022 Bayer AG

The content of this presentation is provided to an audience of international healthcare professionals from around the world for scientific discussion and scientific exchange. Bayer does not recommend the use of any drug substance outside of its approved indications.

 

At the moment of publication, the compound presented has been only approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA). For other approvals, follow your local regulations or health authorities legislation.

 

Last updated on 15/09/2022